Mokhles M. Abd-Elzaher

Prof. Dr. Mokhles M. Abd-Elzaher

National Research Centre, Giza, Al Jīzah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2007 in Applied Organometallic Chemistry
Verified
Journal Article
Closed access
PDF file
MFMohammad F. R. Fouda
Mohammad F. R. Fouda
MAMokhles M. Abd-Elzaher
Mokhles M. Abd-Elzaher
RARafeek A. Abdelsamaia
Rafeek A. Abdelsamaia
ALAmmar A. Labib
Ammar A. Labib

1 April 2001 in Journal of the Chinese Chemical Society
Verified
Journal Article
Closed access
PDF file
MAMokhles M. Abd-Elzaher
Mokhles M. Abd-Elzaher

15 March 2018 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
SMSheta Mohamed Sheta Mohamed
Sheta Mohamed Sheta Mohamed
SESaid El-Sheikh
Said El-Sheikh
MAMokhles M. Abd-Elzaher
Mokhles M. Abd-Elzaher
Novel copper metal organic framework nanoparticles Cu-MOF-NPs (C1) were prepared via two simple alternative methods and confirmed by analytical characterization using mass, IR, Raman, XRD spectrum, HR-TEM and TGA-DSC. Mass spectroscopy revealed the molecular ion peak at 647 m/z for the monomeric unit structure n[Cu(AIP)2(PIY)(H2O)2]·4H2O, the presence of which was further supported by mass fragmentation. The Raman spectrum revealed two separate peaks corresponding to D and G bands of carbon in the structure of C1. Moreover, TGA-DSC showed the presence of CuO. XRD data were typically consistent with Raman and TGA-DSC data. In addition, HR-TEM revealed that the morphology of the C1 nanoparticles is uniform with well-distributed elliptical/spherical particles with a size range from 7 to 19 nm. The spectrophotometric and biological activity studies based on Cu-MOF-NPs were analyzed. The results indicated that Cu-MOF-NPs (C1) were successfully used as biosensors for the assessment of the triiodothyronine hormone (T3). The calibration plot was achieved over the concentration range of 40.0–100.0 ng dl−1 T3 with limits of detection (LOD) and quantitation (LOQ) of 1.46 and 4.85 ng dl−1, respectively, and a correlation coefficient (r) of 0.973. Moreover, the Cu-MOF-NPs (C1) show more enhanced biological activity against various pathogens (five strains of bacteria: Gram positive and Gram negative) when compared to an antibacterial agent and the effectiveness of Cu-MOF-NPs increases with increasing particle dose. The interactions of MOF-NPs (C1) with the biological targets were studied.

1 March 2016 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
MAMokhles M. Abd-Elzaher
Mokhles M. Abd-Elzaher
ALAmmar A. Labib
Ammar A. Labib
HMHanan A. Mousa
Hanan A. Mousa
SMSamia A. Moustafa
Samia A. Moustafa
MAMamdouh M. Ali
Mamdouh M. Ali
AEAhmed A. El-Rashedy
Ahmed A. El-Rashedy
A Schiff base ligand 1 was prepared from condensation of salicyaldehyde with 2-amino-4-phenyl-5-methyl thiazole. The ligand forms complexes with CoII, NiII, CuII, and ZnII in good yield. The synthesized compounds were characterized by elemental analysis, magnetic susceptibility, molar conductance, infrared spectra, 1H and 13C NMR, mass, electronic absorption and ESR spectroscopy. The anticancer activity of the synthesized compounds was studied against different human tumor cell lines: breast cancer MCF-7, liver cancer HepG2, lung carcinoma A549 and colorectal cancer HCT116 in comparison with the activity of doxorubicin as a reference drug. The study showed that ZnII complex showed potent inhibition against human TRK in the four cell lines (HepG2, MCF7, A549, HCT116) by the ratio 80, 70, 61 and 64% respectively as compared to the inhibition in the untreated cells. Moreover, the molecular docking into TRK (PDB: 1t46) was done for the optimization of the aforementioned compounds as potential TRK inhibitors

27 November 2007 in Transition Metal Chemistry
Verified
Journal Article
Closed access
PDF file
MFM. F. R. Fouda
M. F. R. Fouda
MAMokhles M. Abd-Elzaher
Mokhles M. Abd-Elzaher
MSMohammad Shakdofa
Mohammad Shakdofa
FSF. A. El Saied
F. A. El Saied
MAM. I. Ayad
M. I. Ayad
ATA. S. El Tabl
A. S. El Tabl